Cronos Group, a Toronto-based marijuana company, predicts CBD customers in the United States will be the “largest contributor” to its sales over the next... Canadian marijuana giant sees ‘largest’ CBD sales coming from US

But company executives cautioned investors that it’s “too early to speculate” on how big the European market for CBD will become.

The comments came as Cronos released its first earnings report since the company announced plans to spend $300 million in the U.S. hemp market through acquiring four operating subsidiaries of Los Angeles-based Redwood Holding Group.

“It’s fair to estimate that the U.S. CBD market will likely be the largest contributor (to sales) over the next year or two,” Cronos CEO Michael Gorenstein said.
He said the company sees “significant opportunity” for CBD in Europe, but he cautioned against making sales projections.
European health regulators have said that CBD can’t be added to food, a decision the hemp industry in Europe is appealing.
“It’s probably too early to speculate on exactly how quickly the European market will unfold for CBD,” Gorenstein said.
 “I don’t think we have the same clarity as we do for the Canadian market or the U.S.”

Subscribe to our Newsletter

MJ Shareholders avatar

MJ Shareholders is the largest dedicated financial network and leading corporate communications firm serving the legal cannabis industry. Our network aims to connect public marijuana companies with these focused cannabis audiences across the US and Canada that are critical for growth: Short and long term cannabis investors Active funding sources Mainstream media Business leaders Cannabis consumers

No comments so far.

Be first to leave comment below.

( ) ( ) ( ) ( ) ( ) ( ) ( ) ( )